🔎 Trials Near Me

Home › NCT06912776

Novel Visual Education Tool to Improve Recognition and Reporting of Postpartum Urgent Maternal Warning Signs

Recruiting

Who can join

Ages 18 and older · Women

Full eligibility criteria
Inclusion Criteria:

* Postpartum women
* Nulliparity
* Age \>18 years of age
* English speaking patients

Exclusion Criteria:

* Inability to provide informed written consent
* Refusal to participate in all study-related procedures
* Patients not fluent in English
* Patients with current or history of serious peripartum complications and/or events - such as DVT, PE, peripartum cardiomyopathy, etc. (in which the patient may have received more than standard clinical counseling)
* Patient with comorbidities that potentially require anticoagulation i.e. coagulopathies and may be more prone to DVTs
* Patients with uncorrected visual or hearing impairment
* Healthcare providers (in which patients will have significant background knowledge)

About the study

This study aims to create a novel visual education tool that builds on the urgent maternal warning signs identified by The Council on Patient Safety in Women's Health Care. Including effective images will improve the understanding of these grave warning signs/symptoms, improving anatomical accuracy while remaining simplistic for patients of varying levels of health care literacy. The investigative team will be focusing on urgent warning signs pertinent to the postpartum period.

What is being tested

Sponsor: Northwestern University · Participants: 40 · Started: Jun 20, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT06912776

Locations in the U.S.

IllinoisNorthwestern Medicine, Chicago

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.